The worldwide COVID-19 pandemic will inevitably impact the RADAR-AD project. Our project management team is monitoring the situation closely and is in contact with IMI, the funder of the project. In line with measures taken by local governments, the start of the clinical study of RADAR-AD has been postponed to later this year. Postponing the start of the study will help to reduce traffic to and from the hospitals by staff and research participants. This will help to halt the spread of the virus, and helps in protecting our staff and participants. Read the full news story, here: https://www.radar-ad.org/newsroom/impact-covid-19-pandemic-radar-ad
The RADAR-AD project has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 806999.
